A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide (DATE) for De Novo AML: In the Treatment of Young Patients Ages 16-59
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cytarabine; Daunorubicin; Etoposide; Topotecan
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 25 Sep 2012 Biomarkers information updated
- 24 Sep 2005 New trial record.